NLM Digital Collections

Search

Start Over Subjects Opioid-Related Disorders -- economics ✖Remove constraint Subjects: Opioid-Related Disorders -- economics

1. The ABCs of APCDs: how states are using claims data to understand and improve care

Author(s):
Porter, Josephine, author
Love, Denise, author
Publication:
[Oakland, Calif.] : California Health Care Foundation, November 2018
Subject(s):
Databases as Topic
Health Expenditures -- statistics & numerical data
Insurance Claim Review
Chronic Disease -- economics
Cost of Illness
Drug Costs
Health Care Costs
Inappropriate Prescribing -- prevention & control
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- epidemiology
State Government
Humans
California
United States

2. Abuse-deterrent formulations of opioids: effectiveness and value : final evidence report

Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, August 8, 2017
Subject(s):
Abuse-Deterrent Formulations -- economics
Abuse-Deterrent Formulations -- statistics & numerical data
Analgesics, Opioid -- economics
Analgesics, Opioid -- therapeutic use
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- prevention & control
Prescription Drug Diversion -- statistics & numerical data
Comparative Effectiveness Research
Cost-Benefit Analysis
Delayed-Action Preparations -- economics
Delayed-Action Preparations -- therapeutic use
Drug Compounding -- economics
Drug Overdose -- mortality
Insurance Coverage -- economics
Insurance, Pharmaceutical Services -- economics
Opioid-Related Disorders -- epidemiology
Humans
United States

3. CMS should pursue strategies to increase the number of at-risk beneficiaries acquiring naloxone through Medicaid

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Medicaid -- economics
Naloxone -- supply & distribution
Opioid-Related Disorders -- economics
United States
United States. Department of Health and Human Services

4. FDA’s risk evaluation and mitigation strategies: uncertain effectiveness in addressing the opioid crisis

Publication:
Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2020
Subject(s):
Government Regulation
Opioid-Related Disorders -- economics
Risk Evaluation and Mitigation -- legislation & jurisprudence
United States
United States. Department of Health and Human Services
United States. Food and Drug Administration

6. Management of patients with opioid dependence: a review of clinical, delivery system, and policy options

Publication:
[Boston, MA] : Institute for Clinical and Economic Review, July 2014
Subject(s):
Analgesics, Opioid -- therapeutic use
Buprenorphine -- therapeutic use
Comparative Effectiveness Research
Delivery of Health Care
Health Policy
Methadone -- therapeutic use
Naloxone -- therapeutic use
Naltrexone -- therapeutic use
Opiate Substitution Treatment -- economics
Opioid-Related Disorders -- drug therapy
Opioid-Related Disorders -- economics
Opioid-Related Disorders -- rehabilitation
Analgesics, Opioid -- administration & dosage
Analgesics, Opioid -- adverse effects
Budgets
Cohort Studies
Cost-Benefit Analysis
Counseling
Criminal Law
Drug Combinations
Drug Costs
Health Services Accessibility
Insurance Coverage
Medicaid
Medicare
Patient Care Team
Patient-Centered Care
Practice Guidelines as Topic
Treatment Outcome
Humans
New England
United States

10. Opioid use disorder: opportunities to improve assessments of State Opioid Response grant program : report to congressional requesters

Publication:
Washington, DC : United States Government Accountability Office, December 2021
Subject(s):
Data Interpretation, Statistical
Financing, Government -- organization & administration
Government Regulation
Opioid-Related Disorders -- economics
United States
United States. Substance Abuse and Mental Health Services Administration